Prognostic importance of left atrial size measured by non-contrast cardiac computed tomography - A DANCAVAS study.

All cause death Atrial fibrillation Heart failure Left atrial size Non-contrast cardiac computed tomography Thromboembolism

Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 04 2021
Historique:
received: 07 12 2020
accepted: 14 12 2020
pubmed: 29 12 2020
medline: 29 5 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Enlargement of left atrium (LA) is a valuable marker of cardiovascular events, and LA size is readily available while performing non-contrast cardiac computed tomography (NCCT) for preventive purposes. We aimed to evaluate the predictive value of a single LA area from NCCT in a population-based cohort. Mainly men aged 60-75 years from DANCAVAS were included. Traditional risk factors were recorded, and an NCCT scan performed at baseline. Coronary artery calcifications (CAC) score and the largest LA area were measured. LA was indexed to body surface area and categorised into four groups. Data on incident atrial fibrillation (AF), thromboembolic events, heart failure (HF) and death were obtained from Danish national registries. In total, 14,557 individuals were eligible, excluding those without LA measurement (N = 232) and with heart valve replacement (N = 197). Known AF or HF were respectively excluded from follow-up. Median follow-up time was 2.1 to 3.4 years. In total, 304 developed AF, 149 had thromboembolism, 129 developed HF and 482 died. In adjusted analysis, LA enlargement was associated with AF (HR (95% CI): large 1.99 (1.46-2.71) and very large LA 3.77 (2.31-6.14)) and HF (large 2.40 (1.50-3.85) and very large LA 6.54 (4.07-10.51)). A very large LA significantly increased mortality (HR: 2.01 (1.44-2.82)), and was associated with a two-fold increased risk of thromboembolism; however, not significantly in adjusted analysis (p = 0.09). We demonstrated that determination of LA area from NCCT was an important predictor of AF, HF and death. This knowledge could inform current risk assessment beyond CAC score.

Sections du résumé

BACKGROUND
Enlargement of left atrium (LA) is a valuable marker of cardiovascular events, and LA size is readily available while performing non-contrast cardiac computed tomography (NCCT) for preventive purposes. We aimed to evaluate the predictive value of a single LA area from NCCT in a population-based cohort.
METHOD
Mainly men aged 60-75 years from DANCAVAS were included. Traditional risk factors were recorded, and an NCCT scan performed at baseline. Coronary artery calcifications (CAC) score and the largest LA area were measured. LA was indexed to body surface area and categorised into four groups. Data on incident atrial fibrillation (AF), thromboembolic events, heart failure (HF) and death were obtained from Danish national registries.
RESULTS
In total, 14,557 individuals were eligible, excluding those without LA measurement (N = 232) and with heart valve replacement (N = 197). Known AF or HF were respectively excluded from follow-up. Median follow-up time was 2.1 to 3.4 years. In total, 304 developed AF, 149 had thromboembolism, 129 developed HF and 482 died. In adjusted analysis, LA enlargement was associated with AF (HR (95% CI): large 1.99 (1.46-2.71) and very large LA 3.77 (2.31-6.14)) and HF (large 2.40 (1.50-3.85) and very large LA 6.54 (4.07-10.51)). A very large LA significantly increased mortality (HR: 2.01 (1.44-2.82)), and was associated with a two-fold increased risk of thromboembolism; however, not significantly in adjusted analysis (p = 0.09).
CONCLUSION
We demonstrated that determination of LA area from NCCT was an important predictor of AF, HF and death. This knowledge could inform current risk assessment beyond CAC score.

Identifiants

pubmed: 33359284
pii: S0167-5273(20)34277-7
doi: 10.1016/j.ijcard.2020.12.029
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-226

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have nothing to declare.

Auteurs

Maise Hoeigaard Fredgart (MH)

Department of Cardiology, Odense University Hospital, Odense, Denmark; OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark. Electronic address: Maise.Hoigaard.Fredgart@rsyd.dk.

Jes Sanddal Lindholt (JS)

Department of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark; Cardiovascular Centre of Excellence (CAVAC), Denmark; Odense University Hospital, Elitary Research Centre of Individualized Medicine in Arterial Disease (CIMA), Odense, Denmark.

Axel Brandes (A)

Department of Cardiology, Odense University Hospital, Odense, Denmark.

Flemming Hald Steffensen (FH)

Department of Cardiology, Sygehus Lillebaelt, Vejle, Denmark.

Lars Frost (L)

Department of Cardiology, Regional Hospital Central Jutland, Silkeborg, Denmark.

Jess Lambrechtsen (J)

Department of Cardiology, Svendborg Hospital, Svendborg, Denmark.

Marek Karon (M)

Department of Medicine, Nykoebing Falster Hospital, Nykoebing Falster, Denmark.

Martin Busk (M)

Department of Cardiology, Sygehus Lillebaelt, Vejle, Denmark.

Grazina Urbonaviciene (G)

Department of Cardiology, Regional Hospital Central Jutland, Silkeborg, Denmark.

Kenneth Egstrup (K)

Department of Cardiology, Svendborg Hospital, Svendborg, Denmark.

Axel Cosmus Pyndt Diederichsen (ACP)

Department of Cardiology, Odense University Hospital, Odense, Denmark; Odense University Hospital, Elitary Research Centre of Individualized Medicine in Arterial Disease (CIMA), Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH